Literature DB >> 6180207

Role of prostaglandin E1 and copper in angiogenesis.

M Ziche, J Jones, P M Gullino.   

Abstract

The interstitial fluid of MTW9A and Walker carcinomas and their ethanol extract induced strong angiogenic response in the rabbit (New Zealand White) corneal test. The fluid collected in vivo was rich in E-type prostaglandins, and prostaglandin E1 (PGE1) in particular was strongly angiogenic at the lowest dose as compared with the angiogenic responses of prostaglandins E2, I2, and F2 alpha. Neoplastic fibroblasts also induced a strong angiogenic response, but in indomethacin-treated rabbits neovascularization failed to occur. Copper was concentrated in the cornea during PGE1-induced neovascularization, and copper-deficient rabbits were unable to mount an angiogenic response in the corneal test. Ceruloplasmin, the copper carrier of plasma, was found to be angiogenic at high doses. In indomethacin-treated rabbits, however, ceruloplasmin at the same high doses failed to induce angiogenesis. The experiments are interpreted to indicate that angiogenesis is the end result of a sequence of events, two of which are PGE1 production and copper mobilization in the tissue where neovascularization occurs.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6180207

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  70 in total

Review 1.  The role of angiogenesis in rheumatoid arthritis: recent developments.

Authors:  A E Koch
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

Review 2.  Angiogenesis as a target in rheumatoid arthritis.

Authors:  A E Koch
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

3.  Laser photocoagulation for corneal stromal vascularization.

Authors:  V S Nirankari
Journal:  Trans Am Ophthalmol Soc       Date:  1992

4.  X-ray fluorescence microscopy reveals large-scale relocalization and extracellular translocation of cellular copper during angiogenesis.

Authors:  Lydia Finney; Suneeta Mandava; Lyann Ursos; Wen Zhang; Diane Rodi; Stefan Vogt; Daniel Legnini; Jorg Maser; Francis Ikpatt; Olufunmilayo I Olopade; David Glesne
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-05       Impact factor: 11.205

5.  The role of PGE2 receptor EP4 in pathologic ocular angiogenesis.

Authors:  Susan E Yanni; Joshua M Barnett; Monika L Clark; John S Penn
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-06-03       Impact factor: 4.799

6.  Selection and identification of ligand peptides targeting a model of castrate-resistant osteogenic prostate cancer and their receptors.

Authors:  Jami Mandelin; Marina Cardó-Vila; Wouter H P Driessen; Paul Mathew; Nora M Navone; Sue-Hwa Lin; Christopher J Logothetis; Anna Cecilia Rietz; Andrey S Dobroff; Bettina Proneth; Richard L Sidman; Renata Pasqualini; Wadih Arap
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-11       Impact factor: 11.205

7.  Cyclooxygenase-2 and adenylate cyclase/protein kinase A signaling pathway enhances angiogenesis through induction of vascular endothelial growth factor in rat sponge implants.

Authors:  Hideki Amano; Izumi Haysahi; Satoko Yoshida; Hirokuni Yoshimura; Masataka Majima
Journal:  Hum Cell       Date:  2002-03       Impact factor: 4.174

8.  Ethylene vinylacetate copolymer particles dissolved in polyvinyl alcohol (2,000-mer) solution as an embolic material for vascular anomalies. A preliminary study.

Authors:  A Kinoshita; K Yamada; M Ito; M Yamazaki; M Taneda; T Hayakawa
Journal:  Neuroradiology       Date:  1994       Impact factor: 2.804

9.  Do cytokines have any role in Wilson's disease?

Authors:  M K Goyal; S Sinha; S A Patil; V Jayalekshmy; A B Taly
Journal:  Clin Exp Immunol       Date:  2008-10       Impact factor: 4.330

10.  Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts.

Authors:  S Harada; J A Nagy; K A Sullivan; K A Thomas; N Endo; G A Rodan; S B Rodan
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.